Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 86-95 of 254


Re-Engineering Human Embryos[With CGS's Marcy Darnovsky]by Tom AshbrookOn PointApril 28th, 2015Chinese scientists re-engineer human embryo genes, and set off a global moral debate.
Position Statement from the Society for Developmental Biology on Genomic Editing in Human EmbryosSociety for Developmental BiologyApril 24th, 2015Such studies raise deep ethical concerns on their own, and in addition could lead to unanticipated consequences if manipulated embryos were implanted into a womb and allowed to develop to term.
Ethics of Embryo Editing Paper Divides Scientists[Quotes CGS's Marcy Darnovsky]by Sara ReardonNature NewsApril 24th, 2015In March, rumours of the work prompted calls for a moratorium on such research. “No researcher has the moral warrant to flout the globally widespread policy agreement against altering the human germline.”
These are the Countries Where it's 'Legal' to Edit Human Embryos (Hint: the US is One) by Lauren F FriedmanBusiness InsiderApril 23rd, 2015In many places there are no laws preventing a scary "Gattaca scenario," where designer babies become routine — just some loose guidelines and a variable sense of ethics.
Critics Lash Out At Chinese Scientists Who Edited DNA In Human Embryos[Quotes CGS's Marcy Darnovsky]by Rob SteinNPRApril 23rd, 2015For the first time, scientists have edited DNA in human embryos, a highly controversial step long considered off limits.
Editing Human Embryos: So This Happenedby Carl ZimmerNational GeographicApril 22nd, 2015A quick guide to the history behind this research, what the Chinese scientists did, and what it may signify.
Chinese Scientists Genetically Modify Human Embryosby David Cyranoski & Sara ReardonNature NewsApril 22nd, 2015Rumours of germline modification prove true — and look set to reignite an ethical debate.
Public interest group calls for strengthening global policies against human germline modification[Press statement]April 22nd, 2015“No researcher has the moral warrant to flout the globally widespread policy agreement against altering the human germline.”
German regulator puts UniQure gene therapy appraisal on holdby Ludwig BurgerReutersApril 17th, 2015An adviser for biotech drugs to the European Medicines Agency said that Glybera lacked efficacy.
CRISPR Patent Fight Now a Winner-Take-All Matchby Antonio RegaladoMIT Technology ReviewApril 15th, 2015Lab notebooks could determine who was first to invent a revolutionary gene-editing technology.
Displaying 86-95 of 254  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760